Enveric Biosciences Inc ENVB:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/26/21 EST
3.36quote price arrow down-0.06 (-1.75%)
Volume
12,026
Close
3.42quote price arrow down-0.22 (-6.04%)
Volume
603,161
52 week range
2.51 - 21.20

...

Loading . . .

KEY STATS

  • Open3.55
  • Day High3.61
  • Day Low3.31
  • Prev Close3.64
  • 52 Week High21.20
  • 52 Week High Date06/02/20
  • 52 Week Low2.51
  • 52 Week Low Date03/18/20
  • Market Cap62.72M
  • Shares Out18.34M
  • 10 Day Average Volume2.68M
  • Dividend-
  • Dividend Yield-
  • Beta1.88
  • 1 Year % Change-26.92

RATIOS/PROFITABILITY

  • EPS (TTM)-9.31
  • P/E (TTM)-0.37
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-3.713M
  • ROE (MRQ)-55.12%
  • Revenue (MRQ)35.41M
  • Gross Margin (MRQ)20.66%
  • Net Margin (MRQ)-19.34%
  • Debt To Equity (MRQ)51.57%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Enveric Biosciences Inc News

There is no recent news for this security.

Latest ENVB News From Our Partners

QUOTE FINDER

Profile

MORE
Enveric Biosciences Inc., formerly AMERI Holdings, Inc., is a patient-central biotechnology company. The Company is focused on enhancing lives of people affected by the side effects of cancer treatments, such as radiodermatitis and chemotherapy-induced peripheral neuropathy. The Company is engaged in leveraging its clinical developments derived from cannabinoids and taps into its global network of scientists and oncology physicians. The Company is advancing its pipeline of...
David Johnson
Chairman
Avani Kanubaddi
Chief Operating Officer
John Van Buiten
Chief Financial Officer
Address
4851 Tamiami Trail N, Suite 200
Naples, FL
34103
United States